Metastatic Squamous Cell Carcinoma of the Lung: ASCO Tumor Boards

This is a case-based activity that includes discussion of a 63 year old woman with a history of hypertension who presents to her primary care physician with a two-month history of shortness of breath on moderate exertion and a dry cough. The patient is a current one pack per day cigarette smoker for the past 32 years. A chest x-ray and CT scan of the chest and upper abdomen show a 4.2 cm right lower lobe central lung mass, subcarinal lymphadenopathy, and several liver lesions concerning for metastases. A CT-guided biopsy of the liver lesion is performed, showing squamous cell carcinoma.

Learning Objectives

  • Describe the role of first-line systemic therapy for patients with metastatic lung squamous cell carcinomas
  • Recognize options for the treatment of relapsed/refractory squamous cell carcinoma of the lung
  • Analyze the role of novel approaches including immunotherapy and targeted therapies in lung squamous cell carcinoma

Continuing Education Credit

1 Credit/Point is available for participation in this course. Certificate and credit types available includes:

  • AMA PRA Category 1 Credits™ 
  • Certificate of Participation may be used to confer credit; however, all final decisions regarding the awarding of credits will be made by the licensing organization to which the credits are submitted.
  • Certificate of Completion may be used to document participation, but no credit will be conferred.

Important Notes

  • This course expires on February 17, 2019. Participants must complete all necessary course components by this date.
  • This course is available as part of the 2016 ASCO Tumor Boards bundle.